Page last updated: 2024-09-02

1-(carboxymethylthio)tetradecane and Metabolic Diseases

1-(carboxymethylthio)tetradecane has been researched along with Metabolic Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bisgaier, CL; Cramer, CT; Dasseux, JL; Denisenko, S; Duan, C; Freiman, CD; Geoffroy, OJ; Goetz, B; Hopson, KL; Huang, TB; McCosar, BH; Mueller, R; Oniciu, DC; Pape, ME; Pop, E; Yang, J; Zhang, LH1

Other Studies

1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Metabolic Diseases

ArticleYear
Long hydrocarbon chain keto diols and diacids that favorably alter lipid disorders in vivo.
    Journal of medicinal chemistry, 2004, Nov-18, Volume: 47, Issue:24

    Topics: Alcohols; Animals; Cells, Cultured; Cholesterol, HDL; Diabetes Mellitus; Dicarboxylic Acids; Dose-Response Relationship, Drug; Female; Hepatocytes; Hydrocarbons; Hyperlipidemias; Hypolipidemic Agents; Keto Acids; Ketones; Lipids; Male; Metabolic Diseases; Rats; Rats, Sprague-Dawley; Rats, Zucker

2004